Literature DB >> 31539059

Personal and Clinical Vaginal Lubricants: Impact on Local Vaginal Microenvironment and Implications for Epithelial Cell Host Response and Barrier Function.

Ellen M Wilkinson1,2, Paweł Łaniewski3, Melissa M Herbst-Kralovetz1,3, Rebecca M Brotman4.   

Abstract

BACKGROUND: A majority of US women report past use of vaginal lubricants to enhance the ease and comfort of intimate sexual activities. Lubricants are also administered frequently in clinical practice. We sought to investigate if hyperosmolar lubricants are toxic to the vaginal mucosal epithelia.
METHODS: We tested a panel of commercially available lubricants across a range of osmolalities in human monolayer vaginal epithelial cell (VEC) culture and a robust 3-dimensional (3-D) VEC model. The impact of each lubricant on cellular morphology, cytotoxicity, barrier targets, and the induction of inflammatory mediators was examined. Conceptrol, containing nonoxynol-9, was used as a cytotoxicity control.
RESULTS: We observed a loss of intercellular connections, and condensation of chromatin, with increasing lubricant osmolality. EZ Jelly, K-Y Jelly, Astroglide, and Conceptrol induced cytotoxicity in both models at 24 hours. There was a strong positive correlation (r = 0.7326) between lubricant osmolality and cytotoxicity in monolayer VECs, and cell viability was reduced in VECs exposed to all the lubricants tested for 24 hours, except McKesson. Notably, select lubricants altered cell viability, barrier targets, and inflammatory mediators in 3-D VECs.
CONCLUSIONS: These findings indicate that hyperosmolar lubricants alter VEC morphology and are selectively cytotoxic, inflammatory, and barrier disrupting in the 3-D VEC model.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  3-D cell culture; cytotoxicity; genital inflammation; human vaginal epithelial cells; inflammatory mediators; nonoxynol-9; vaginal lubricants

Mesh:

Substances:

Year:  2019        PMID: 31539059      PMCID: PMC6834067          DOI: 10.1093/infdis/jiz412

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  42 in total

1.  The immune response to AIDS virus infection: good, bad, or both?

Authors:  Steven G Deeks; Bruce D Walker
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

2.  The effects of vaginal lubricants on sperm function: an in vitro analysis.

Authors:  Alex Mowat; Cora Newton; Clare Boothroyd; Kristy Demmers; Steven Fleming
Journal:  J Assist Reprod Genet       Date:  2014-01-05       Impact factor: 3.412

Review 3.  Innate immunity and inflammatory response to Trichomonas vaginalis and bacterial vaginosis: relationship to HIV acquisition.

Authors:  Andrea R Thurman; Gustavo F Doncel
Journal:  Am J Reprod Immunol       Date:  2011-02       Impact factor: 3.886

Review 4.  In vitro and in vivo: the story of nonoxynol 9.

Authors:  Sharon L Hillier; Thomas Moench; Robin Shattock; Roberta Black; Patricia Reichelderfer; Fulvia Veronese
Journal:  J Acquir Immune Defic Syndr       Date:  2005-05-01       Impact factor: 3.731

5.  Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection.

Authors:  Rebecca M Brotman; Mark A Klebanoff; Tonja R Nansel; Kai F Yu; William W Andrews; Jun Zhang; Jane R Schwebke
Journal:  J Infect Dis       Date:  2010-11-10       Impact factor: 5.226

6.  The mucosa of the rabbit vagina: a proposed experimental model for correlated morphofunctional studies in humans.

Authors:  F Barberini; F De Santis; S Correr; P M Motta
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1992-05-13       Impact factor: 2.435

7.  Functions of MUC16 in corneal epithelial cells.

Authors:  Timothy D Blalock; Sandra J Spurr-Michaud; Ann S Tisdale; Susan R Heimer; Michael S Gilmore; Vijaya Ramesh; Ilene K Gipson
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-10       Impact factor: 4.799

8.  Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society.

Authors: 
Journal:  Menopause       Date:  2013-09       Impact factor: 2.953

9.  The CLOSER survey: impact of postmenopausal vaginal discomfort on relationships between women and their partners in Northern and Southern Europe.

Authors:  Rossella E Nappi; Lars-Åke Mattsson; Michèle Lachowsky; Ricardo Maamari; Annamaria Giraldi
Journal:  Maturitas       Date:  2013-05-31       Impact factor: 4.342

10.  Intravaginal practices and risk of bacterial vaginosis and candidiasis infection among a cohort of women in the United States.

Authors:  Joelle M Brown; Kristen L Hess; Stephen Brown; Colleen Murphy; Ava Lena Waldman; Marjan Hezareh
Journal:  Obstet Gynecol       Date:  2013-04       Impact factor: 7.661

View more
  9 in total

1.  Members of Prevotella Genus Distinctively Modulate Innate Immune and Barrier Functions in a Human Three-Dimensional Endometrial Epithelial Cell Model.

Authors:  Zehra Esra Ilhan; Paweł Łaniewski; Adriana Tonachio; Melissa M Herbst-Kralovetz
Journal:  J Infect Dis       Date:  2020-11-13       Impact factor: 5.226

2.  Lactic acid-containing products for bacterial vaginosis and their impact on the vaginal microbiota: A systematic review.

Authors:  Erica L Plummer; Catriona S Bradshaw; Michelle Doyle; Christopher K Fairley; Gerald L Murray; Deborah Bateson; Lindi Masson; Josephine Slifirski; Gilda Tachedjian; Lenka A Vodstrcil
Journal:  PLoS One       Date:  2021-02-11       Impact factor: 3.240

3.  Observational cohort study of the effect of a single lubricant exposure during transvaginal ultrasound on cell-shedding from the vaginal epithelium.

Authors:  D Elizabeth O'Hanlon; Sarah E Brown; Xin He; Christina A Stennett; Sarah J Robbins; Elizabeth D Johnston; Amelia M Wnorowski; Katrina Mark; Jacques Ravel; Richard A Cone; Rebecca M Brotman
Journal:  PLoS One       Date:  2021-05-03       Impact factor: 3.240

Review 4.  Interventions Preventing Vaginitis, Vaginal Atrophy after Brachytherapy or Radiotherapy Due to Malignant Tumors of the Female Reproductive Organs-A Systematic Review.

Authors:  Adrianna Wierzbicka; Dorota Mańkowska-Wierzbicka; Stanisław Cieślewicz; Marta Stelmach-Mardas; Marcin Mardas
Journal:  Int J Environ Res Public Health       Date:  2021-04-08       Impact factor: 3.390

5.  Impact of vaginal douching products on vaginal Lactobacillus, Escherichia coli and epithelial immune responses.

Authors:  Helai Hesham; Alissa J Mitchell; Agnes Bergerat; Kristin Hung; Caroline M Mitchell
Journal:  Sci Rep       Date:  2021-11-29       Impact factor: 4.379

6.  Vaginal cytokine profile and microbiota before and after lubricant use compared with condomless vaginal sex: a preliminary observational study.

Authors:  Susan Tuddenham; Christina A Stennett; Richard A Cone; Jacques Ravel; Andrew N Macintyre; Khalil G Ghanem; Xin He; Rebecca M Brotman
Journal:  BMC Infect Dis       Date:  2021-09-18       Impact factor: 3.090

7.  Clinical and Personal Lubricants Impact the Growth of Vaginal Lactobacillus Species and Colonization of Vaginal Epithelial Cells: An in Vitro Study.

Authors:  Paweł Łaniewski; Kimberley A Owen; Michael Khnanisho; Rebecca M Brotman; Melissa M Herbst-Kralovetz
Journal:  Sex Transm Dis       Date:  2021-01       Impact factor: 2.830

Review 8.  The interplay between the vaginal microbiome and innate immunity in the focus of predictive, preventive, and personalized medical approach to combat HPV-induced cervical cancer.

Authors:  Erik Kudela; Alena Liskova; Marek Samec; Lenka Koklesova; Veronika Holubekova; Tomas Rokos; Erik Kozubik; Terezia Pribulova; Kevin Zhai; Dietrich Busselberg; Peter Kubatka; Kamil Biringer
Journal:  EPMA J       Date:  2021-05-18       Impact factor: 8.836

9.  Effect of commercial vaginal products on the growth of uropathogenic and commensal vaginal bacteria.

Authors:  Kristin J Hung; Patricia L Hudson; Agnes Bergerat; Helai Hesham; Namit Choksi; Caroline Mitchell
Journal:  Sci Rep       Date:  2020-05-06       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.